Keytruda
Americans have been urged to take precautions to protect against ultraviolet (UV) radiation and skin cancer during the hotter months of the year. In a statement issued by the US Food and Drug Administration (FDA), FDA Commissioner Scott Gottlieb, MD, highlighted the dangers and prevalence of skin...
Read More... Jun 15, 2018Melanoma
Melanoma
Melanoma is a form of skin cancer that attacks the skin's pigment, which is called melanin. It is most commonly found in areas of the skin regularly exposed to the sun, but may also develop in the eyes, internal organs, and intestines.
Symptoms of melanoma include the appearance of a new, abnormal-looking mole, or a change in the shape and color of an existing mole. Signs to watch for in moles are irregular shapes, multiple colors, or an uneven distribution of color.
It is usually caused by exposure to ultraviolet radiation, for example, tanning beds, lamps, and sunlight. Other risk factors include: being female and over 40, paler skin, and family history of melanoma.
Melanoma is usually diagnosed with a biopsy and treatment includes surgical options, such as removal of affected areas. Medication in the form of chemotherapy and radiation therapy may also be part of melanoma treatment.
Drug classes often used to treat melanoma include protein kinase inhibitors, interferon alphas, antineoplastic monoclonal antibodies, and PD inhibitors.
Drugs Used To Treat Melanoma:
Lab Test Categories Related to Melanoma:
Drugs related to Melanoma:
Blog Posts Related to Melanoma:
Pharmaceutical manufacturer Sanofi has announced that the US Food and Drug Administration (FGA) has granted Breakthrough Therapy Designation to Cemiplimab (REGN2810) as a treatment for adults with metastatic cutaneous squamous cell carcinoma (CSCC) and adults with locally advanced and unresectable...
Read More... Sep 23, 2017The US Food and Drug Administration (FDA) has issued a statement clarifying its position on Keytruda (pembrolizumab) after scientists monitoring studies of the drug found an excess of deaths among patients given the drug in combination with certain other medicines. Currently, Keytruda is...
Read More... Sep 10, 2017The US Food & Drug Administration's (FDA) decision to approve a medication to treat patients whose cancer has a specific genetic feature, or biomarker, has been hailed as an "important first" in the fight against the disease. Keytruda (pembrolizumab) is a monoclonal antibody already in use to...
Read More... May 24, 2017
Share ModRN Health and Earn Rewards!
Login or Register to Share!
For every friend or family member you refer you will earn 100 Reward Points on their first prescription purchase! Plus you earn Reward Points on every prescription purchase they make with their ModRN Health card.
You may share without logging in or registering, but please note you will not receive any reward points.
Search
Set your Location
Or